Login to Your Account

Finding its ‘niche’: start-up Scholar Rock targeting growth factors

By Jennifer Boggs
Managing Editor

Thursday, February 27, 2014
Scholar Rock Inc. CEO Nagesh Mahanthappa’s previous biopharma experiences include stints at RNAi powerhouse Alnylam Pharmaceuticals Inc. and privately held Avila Therapeutics Inc., and he is the first to admit that “those are high standards.”

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription